Kara Klinkebiel

Kara Klinkebiel

Auto-generated profile, based on publicly available information

Kara Klinkebiel

Department of Pediatrics (A.O., K.K., R.L., B.P.C., K.T., V.G., M.L.M.), The Ohio State University College of Medicine, Columbus, OH

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2026 in Circulation: Genomic and Precision Medicine
Verified
Journal Article
Closed access
AOAngela Onorato
Angela Onorato
KKKara Klinkebiel
Kara Klinkebiel
RLRachel Levenseller
Rachel Levenseller
BCBimal Chaudhari
Bimal Chaudhari
IKIsaac Kistler
Isaac Kistler
MMMay Ling Mah
May Ling Mah
BACKGROUND: Genetic variation affects clinical outcomes, prognosis, and family planning decisions in individuals with congenital heart disease (CHD). While genetic testing recommendations for infants and children with CHD have expanded, similar broad guidelines are lacking for patients with adult CHD (ACHD). Here, we investigated the current state of genetic testing in patients with ACHD and their perceptions toward testing, which has not been previously reported. METHODS: A single-center prospective cohort survey of patients with ACHD aged ≥18 years was evaluated in a large ACHD clinic over a 12-month period. RESULTS: Among 336 survey respondents (median age, 29 years; 52% male), CHD lesions were wide ranging, albeit largely represented by conotruncal (35%) or left ventricular outflow tract (35%) lesions. Most patients did not have children (64%) or a family history of CHD (79%). Thirteen percent had evidence of prior genetic testing despite 41% to 98% meeting criteria by current pediatric recommendations. Most desired genetic testing (68%) though interest varied by sex, education level, and family status. Individual and family health factors were reported as the most influential considerations for genetic testing. CONCLUSIONS: Few patients with ACHD have had genetic testing despite most being eligible based on current pediatric guidelines, likely related to birth era. Patients were interested in genetic testing though demographic factors and family status affected interest. The lack of broad recommendations for genetic testing in the ACHD population likely represents a significant barrier to increased utilization of genetic tests.